Ophthalmic pharmaceutical company Visus Therapeutics introduced six new executives it has appointed to lead the company.
The six appointments are Tim Grinstead as COO; James Burke as vice president of research; Patrick Hughes, PhD, as vice president of pharmaceutical development; Lisa Simpson as vice president of clinical operations and compliance; Guru Sharma, OD, as director of ophthalmology and clinical development; and Alex Oh as vice president of intellectual property.
Visus Therapeutics is a clinical-stage company with offices in Seattle and Orange County, Calif.